The increasing interest in successful weight management has spurred considerable exploration into cutting-edge treatments. Recently , Retatrutide, a combined -action glucose-dependent insulinotropic polypeptide (GIP) and peptide receptor stimulator, has exhibited promising results in patient trials, indicating potential for significant weight loss